Choosing the Right Method For Competitive Analysis
But also new types of Therapies are coming into the game, from behavioral changes such as diets, physical exercise, and sleep schedules, to digital applications which become more and more “prescribable”. Additionally, the “old” fight; proprietary vs. generic becomes more relevant, the more therapies are competing in the market. This leaves the brand with the questions of differentiation. Many such topics were discussed and reiterated at NextPharma’22 Summit.
“How good are you relative to your competitor in the respective attribute, in the eyes of your customer?”
Obviously, you can do this exercise in an Excel sheet. However, this becomes quite cumbersome, quickly. There are some tools out there that help you organize this analysis. The one showing the most flexibility and user experience would be Enavia’s Relative Competitive Analysis tool (www.enaviahub.com).
My team and I will be happy to support you in your Competitive Analytics and strategic decision making. Please reach out for a free consultation.
Daniel Kohlstaedt
Managing Director
About the author:
Daniel Kohlstaedt is the Managing Director of PurpleLeaf Strategy, with almost 20 years of pharmaceutical commercial excellence experience. PurpleLeaf has created the a set of light tools to uncover the differentiation potential of any pharmaceutical brand in relation to its competitors, which sharpens the overall strategic decision making.
All tools are cloud-based and can be simply integrated into the existing brand strategy development approach.
Contact us to learn how we can boost your strategic decisions.